|
AEVIS VICTORIA SA / Key word(s): Development of Sales Ad hoc announcement pursuant to Art. 53 LR Fribourg, 9 March 2023 AEVIS VICTORIA SA (AEVS:SW) – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year. Organic growth accelerated to 11.8%, driven by the hotel business. The Fribourg-based investment company AEVIS VICTORIA SA (AEVIS) achieved revenues of CHF 1.143bn in 2022, up 27.8% from prior year. The excellent results were amongst others driven by normalized conditions for the hotel industry and the consolidation of Hôpital du Jura Bernois SA. On a like-for-like basis, organic growth amounted to 11.8%. The Group’s various divisions improved their results and the company will propose the distribution of a dividend to the Annual General Meeting. Swiss Medical Network SA, the Group's subsidiary active in hospitals and healthcare organizations, achieved revenues of CHF 915.8m, up 20.5% (2021: CHF 760.1m). Consolidated over 12 months, Hôpital du Jura Bernois SA (HJB) significantly contributed to this revenue increase, organic growth standing at 3.7%. Visana Beteiligungen AG entered into the capital of HJB early 2023, thus reducing Swiss Medical Network's stake from 52% to 35.1%. HJB will therefore no longer be consolidated in 2023. At the same time, Hôpital du Jura Bernois SA became Réseau de l'Arc SA, the first real integrated care organization in Switzerland. The partnership with Visana will enable Réseau de l'Arc to offer its own health plan in September 2023, valid from 1 January 2024 and available to all inhabitants of the Jura Arc. Victoria-Jungfrau AG, the group’s hospitality division, grew by 35.1% to CHF 154.5m (2021: CHF 114.3m), with activity returning to levels witnessed in 2019. Organic growth was 30.2% and even 72.9% when excluding hardship indemnities received in 2021. MICE business (meetings, incentives, conventions, exhibitions) is gradually returning to normal but will not reach its pre-crisis levels before 2024. This activity has been largely offset by an increase in the number of individual customers. Since the beginning of 2023, the hotel activity remained solid. Other revenues (real estate, investments and miscellaneous) contribute by approximately CHF 70m to Group revenues. AEVIS will publish its complete and detailed results on 31 March 2023. For further information: AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich AEVIS VICTORIA SA - Investing for a better life AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA (90%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, Victoria-Jungfrau AG, a luxury hotel group managing ten luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.
End of Inside Information |
1577993 09-March-2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
Special
